Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
about
The staphylococcal enterotoxin (SE) family: SEB and siblingsA mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.Increased neutrophil extracellular trap-mediated Staphylococcus aureus clearance through inhibition of nuclease activity by clindamycin and immunoglobulinIntravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.Staphylococcal superantigens cause lethal pulmonary disease in rabbits.Staphylococcal and streptococcal superantigen exotoxinsIntravenous immune globulins: an update for clinicians.Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infectionThe evolving field of biodefence: therapeutic developments and diagnostics.Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells.Human immune proteome in experimental colonization with Staphylococcus aureus.Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin.Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model.Commercial Intravenous Immunoglobulin (IVIg) Preparations Contain Functional Neutralizing Antibodies Against the Staphylococcus aureus Leukocidin LukAB (LukGH).Biocompatibility of pooled human immunoglobulin (Gamunex 10%™) with ocular infusion solutions (BSS™ and BSS Plus™): an in vitro evaluation of a potential antitoxin treatment for infectious endophthalmitis.Disseminated sepsis due to a Panton-Valentine leukocidin producing strain of community acquired meticillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy.Panton-Valentine leukocidin-producing Staphylococcus aureus infections: report of 4 French cases.Immunoglobulin E to staphylococcal and streptococcal toxins in patients with chronic sinusitis/nasal polyposis.Immunization with a nontoxic mutant of staphylococcal enterotoxin A, SEAD227A, protects against enterotoxin-induced emesis in house musk shrews.Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers
P2860
Q26830220-1DA7D6A0-65BE-4262-9A18-4FD93B759099Q33558510-9B0DDE35-BFA2-4ABC-8DFD-CE50ABEE1CC0Q33719201-26E9B866-4B02-4836-9487-2FE7ECD22FC8Q33880228-D83FECCF-C1B2-41AC-A602-F208AA41AD29Q34123551-5F70504E-FF3A-4DD1-B129-DD354A580702Q34280083-C723018B-CC07-44A1-9F6F-E724BD6AF94BQ34355243-1296A6C0-1C71-428E-946D-C8074839F41DQ35542385-0EA1621C-2866-4A98-A611-169C29B25CD7Q35880774-010A4510-DDDF-4E71-AC13-B3A05B2FA7F2Q36085668-C143C15B-5A69-452E-9B45-2D609498E597Q36910011-2D6F143D-94BE-4F5F-9A3C-887FCE6E69B0Q37410029-A64B7602-5938-494B-9306-4F2A93CD90B3Q39392633-415B1F3A-341D-431A-94B0-D8EE5F415D16Q39780890-AC2E6FE4-AD9D-4534-B02E-BB54FE488562Q40065980-E419EC13-1861-4608-A7F7-F59B7F971621Q41860270-2A38C8B0-1927-4621-BA04-DF6901669383Q42723236-08A8EC14-FE86-41E5-9938-E63CC37899F9Q43482223-80DCA810-BB35-46B7-B113-A0348556BA46Q53609217-CE549814-6415-4C6A-9EBB-9E3E54798969Q54411256-5FFF284F-20B0-4752-AA91-7723EB87C53FQ57001299-31B4B5E3-7315-420B-8A64-C3F07B57E70F
P2860
Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@ast
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@en
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@nl
type
label
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@ast
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@en
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@nl
prefLabel
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@ast
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@en
Use of intravenous immunoglobu ...... ndromes and related illnesses.
@nl
P356
P1476
Use of intravenous immunoglobu ...... yndromes and related illnesses
@en
P2093
Schlievert PM
P304
P356
10.1067/MAI.2001.117820
P407
P433
P577
2001-10-01T00:00:00Z